Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$60.75
-2.44-3.86%
Last update: Oct 14, 11:51 AM
$64.49
1.302.06%
Celcuity Inc (CELC) Stock Price, Quote, News & History
CELCNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors. Its candidate, gedatolisib, is a kinase inhibitor of the PI3K/AKT/mTOR (PAM) pathway, binding all class I PI3K isoforms and mTORC1/2,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Celcuity (NASDAQ:CELC) through any online brokerage.
Other companies in Celcuity’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Celcuity has a consensus price target of $127.43.
The stock price for Celcuity (NASDAQ: CELC) is $60.75 last updated October 14, 2026 at 11:51 AM EDT.
There are no upcoming dividends for Celcuity.
Celcuity does not have any upcoming earnings scheduled.
There is no upcoming split for Celcuity.
Celcuity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
